GES holds a South African Products Health Regulatory Authority (SAHPRA) manufacturing authorization (License No: 1401.-.2) that authorises us in accordance to Section 22C(1)(b) of the Medicines and Related substances Act, 1965 (Act 101 of 1965) to import, export, manufacture, pack, label and distribute cannabinoid containing products as well as a GMP certificate (26/7/3/31/1/G0053/2023). We also hold a written confirmation of GMP for export of active substances into the European Union for medicinal products for human use, in accordance with Article 46b(2)(b) of Directive 2001/83/EC. View GESLabs SAHPRA licence here.